Investors
Moberg Pharma’s share is listed on the main list at NASDAQ OMX Stockholm. Moberg Pharma’s goal is to create value and provide attractive shareholder returns through the successful commercialization of its pipeline assets.
Aktiekurs 17 Jun 2013 14:30
33.90 kr
1.19 %
33.90 kr
1.19 %
- All pressreleases
- Regulatory
2024-05-07 | Press release
2024-05-06 | Press release
2024-04-23 | Press release
2024-05-07 | Press release
2024-04-12 | Press release
2024-04-12 | Press release
Interview with CEO Anna Ljung
Contact Investor
relations:
Anna Ljung, CEO
Tel. +46 (0)8 522 307 01
Email: anna.ljung@mobergpharma.se